Bronchitis Treatment Market by Treatments (Oxygen Therapy and Drugs), Drugs Class (Anti-inflammatory Drugs, Antibiotics, Mucolytics, and Bronchodilators), End-users (Hospitals, Clinics, and Drug Stores), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global bronchitis treatment market size is estimated to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the large patient control and increasing competitive activities of advancement of bronchitis treatment products.
Bronchitis refers to festering of the bronchial tubes that provide air to the lungs. Some other symptoms are wheezing, shortness of breath, low fever, and tight chest; among these cough with mucus is found to be a common condition of the patient suffering from the disorder. It is a respiratory disease where inflammation occurs of the bronchi within lungs.
The restraining elements that accelerate the chances of bronchitis are gastric reflux, cigarette smoking, and exposure to irritants during work such as chemicals, dust, and fumes. Additionally, it is most common that it usually occurs when the infection is becoming very intense into the lungs. This infection is the reason of air sacs in the lungs, which is filled with fluid.
The two types of bronchitis are acute bronchitis and chronic bronchitis. Acute bronchitis is a temporary condition of the disease infection in the lungs, which is also called as a chest cold. Most of the cases of acute bronchitis are caused by viruses and some of the most common symptom of acute bronchitis are fever, cough, wheezing, and shortness of breath. Meanwhile, chronic bronchitis, also known as chronic obstructive pulmonary disease, is a prolonged and long–term disease infection in the lungs. It is caused by airway tissue, damage to the lung and repeated irritation.
Market Trends, Drivers, Restraints, and Opportunities
- Presence of a large pool of the targeted patients globally due to unhealthy habits such as smoking presents a key driver of the market.
- Rising level of chemical pollutants in the air and increasing cases of lung infections worldwide are some major factors boosting the market growth.
- Wide availability of advanced treatment for bronchitis and lungs infections are expected to fuel the market growth.
- Establishment of well-equipped healthcare infrastructure and facilities for the chronic disease treatment is driving the market expansion.
- Increasing drugs patent expiry for the disease treatment is expected to hamper the growth of the market.
Scope of Bronchitis Treatment Market Report
The report on the global bronchitis treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Bronchitis Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Treatments (Drugs and Oxygen Therapy), Drugs Class (Antibiotics, Anti-inflammatory Drugs, Bronchodilators, and Mucolytics), End-users (Hospitals, Clinics, and Drug Stores) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Boehringer Ingelheim; Dr. Reddy’s Laboratories Ltd; GlaxoSmithKline Pharmaceuticals Limited; Pfizer Inc.; and Sanofi Aventis. |
Bronchitis Treatment Market Segment Insights
Drugs segment is expected to grow at a rapid pace
Based on treatments, the global bronchitis treatment market is bifurcated into oxygen therapy and drugs. The drugs segment accounted for a key share of the market in 2020 and is expected to grow at a rapid pace during the projected period due to advancement in the drug manufacturing technology. However, the oxygen therapy segment is anticipated to expand at a significant growth rate during the forecast period owing to increase in the adoption rate of the therapy for the particular disease treatment.
Antibiotics segment is projected to expand at a considerable CAGR
On the basis of drugs class, the market is divided into bronchodilators, anti-inflammatory drugs, bronchodilators, antibiotics, and mucolytics. The antibiotics segment is projected to expand at a considerable CAGR during the forecast period owing to low cost and easy availability of the drug type. Meanwhile, the mucolytics segment is anticipated to represent a healthy growth rate during the forecast period due to increasing demand for the drug among patients.
Hospitals segment is expected to exhibit a robust growth rate
Based on end-users, the global bronchitis treatment market is segmented into drug stores, clinics, and hospitals. The hospitals segment held a dominant share of the market in 2019 and is expected to exhibit a robust growth rate in the coming years due to large number of increasing chronic diseases and frequent hospital visit by patients for the treatment. On the other hand, the clinics part is anticipated to hold a large market share during the projected period owing to rapid expansion of several clinics facilitating easy access at low cost.
North America is anticipated to constitute a key market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period due to increasing number of patients and rapid adoption of advanced treatment methods for various diseases in the region. The market of Asia Pacific, however, is expected to register a substantial growth rate in the coming years owing to increasing healthcare infrastructure and facilities under several governments’ initiatives in the region.
Segments
The global bronchitis treatment market has been segmented on the basis of
Treatments
- Drugs
- Oxygen Therapy
Drugs Class
- Antibiotics
- Anti-inflammatory Drugs
- Bronchodilators
- Mucolytics
End-users
- Hospitals
- Clinics
- Drug Stores
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Boehringer Ingelheim
- Dr. Reddy’s Laboratories Ltd
- GlaxoSmithKline Pharmaceuticals Limited
- Pfizer Inc.
- Sanofi Aventis
Competitive Landscape
Key players competing in the global bronchitis treatment market are Boehringer Ingelheim; Dr. Reddy’s Laboratories Ltd; GlaxoSmithKline Pharmaceuticals Limited; Pfizer Inc.; and Sanofi Aventis. These main market players are continuously engaged in various business development activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations to expand their business operations and widen their geographical reach.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bronchitis Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bronchitis Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bronchitis Treatment Market - Supply Chain
4.5. Global Bronchitis Treatment Market Forecast
4.5.1. Bronchitis Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bronchitis Treatment Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Bronchitis Treatment Market Absolute $ Opportunity
5. Global Bronchitis Treatment Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Bronchitis Treatment Market Size and Volume Forecast by End Users
5.3.1. Hospitals Clinics Drug Stores
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Bronchitis Treatment Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Bronchitis Treatment Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Bronchitis Treatment Demand Share Forecast, 2019-2026
7. North America Bronchitis Treatment Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Bronchitis Treatment Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Bronchitis Treatment Market Size and Volume Forecast by End Users
7.4.1. Hospitals Clinics Drug Stores
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Bronchitis Treatment Demand Share Forecast, 2019-2026
8. Latin America Bronchitis Treatment Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Bronchitis Treatment Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Bronchitis Treatment Market Size and Volume Forecast by End Users
8.4.1. Hospitals Clinics Drug Stores
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Bronchitis Treatment Demand Share Forecast, 2019-2026
9. Europe Bronchitis Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Bronchitis Treatment Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Bronchitis Treatment Market Size and Volume Forecast by End Users
9.4.1. Hospitals Clinics Drug Stores
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Bronchitis Treatment Demand Share Forecast, 2019-2026
10. Asia Pacific Bronchitis Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Bronchitis Treatment Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Bronchitis Treatment Market Size and Volume Forecast by End Users
10.4.1. Hospitals Clinics Drug Stores
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Bronchitis Treatment Demand Share Forecast, 2019-2026
11. Middle East & Africa Bronchitis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Bronchitis Treatment Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Bronchitis Treatment Market Size and Volume Forecast by End Users
11.4.1. Hospitals Clinics Drug Stores
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Bronchitis Treatment Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Bronchitis Treatment Market: Market Share Analysis
12.2. Bronchitis Treatment Distributors and Customers
12.3. Bronchitis Treatment Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Boehringer Ingelheim Dr. Reddy’s Laboratories Ltd GlaxoSmithKline Pharmaceuticals Limited Pfizer Inc. Sanofi Aventis
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bronchitis Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bronchitis Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bronchitis Treatment Market - Supply Chain
4.5. Global Bronchitis Treatment Market Forecast
4.5.1. Bronchitis Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bronchitis Treatment Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Bronchitis Treatment Market Absolute $ Opportunity
5. Global Bronchitis Treatment Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Bronchitis Treatment Market Size and Volume Forecast by End Users
5.3.1. Hospitals Clinics Drug Stores
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Bronchitis Treatment Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Bronchitis Treatment Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Bronchitis Treatment Demand Share Forecast, 2019-2026
7. North America Bronchitis Treatment Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Bronchitis Treatment Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Bronchitis Treatment Market Size and Volume Forecast by End Users
7.4.1. Hospitals Clinics Drug Stores
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Bronchitis Treatment Demand Share Forecast, 2019-2026
8. Latin America Bronchitis Treatment Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Bronchitis Treatment Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Bronchitis Treatment Market Size and Volume Forecast by End Users
8.4.1. Hospitals Clinics Drug Stores
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Bronchitis Treatment Demand Share Forecast, 2019-2026
9. Europe Bronchitis Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Bronchitis Treatment Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Bronchitis Treatment Market Size and Volume Forecast by End Users
9.4.1. Hospitals Clinics Drug Stores
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Bronchitis Treatment Demand Share Forecast, 2019-2026
10. Asia Pacific Bronchitis Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Bronchitis Treatment Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Bronchitis Treatment Market Size and Volume Forecast by End Users
10.4.1. Hospitals Clinics Drug Stores
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Bronchitis Treatment Demand Share Forecast, 2019-2026
11. Middle East & Africa Bronchitis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Bronchitis Treatment Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Bronchitis Treatment Market Size and Volume Forecast by End Users
11.4.1. Hospitals Clinics Drug Stores
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Bronchitis Treatment Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Bronchitis Treatment Market: Market Share Analysis
12.2. Bronchitis Treatment Distributors and Customers
12.3. Bronchitis Treatment Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Boehringer Ingelheim Dr. Reddy’s Laboratories Ltd GlaxoSmithKline Pharmaceuticals Limited Pfizer Inc. Sanofi Aventis
The global bronchitis treatment market has been segmented on the basis of
Treatments
- Drugs
- Oxygen Therapy
Drugs Class
- Antibiotics
- Anti-inflammatory Drugs
- Bronchodilators
- Mucolytics
End-users
- Hospitals
- Clinics
- Drug Stores
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Boehringer Ingelheim
- Dr. Reddy’s Laboratories Ltd
- GlaxoSmithKline Pharmaceuticals Limited
- Pfizer Inc.
- Sanofi Aventis
Key players competing in the global bronchitis treatment market are Boehringer Ingelheim; Dr. Reddy’s Laboratories Ltd; GlaxoSmithKline Pharmaceuticals Limited; Pfizer Inc.; and Sanofi Aventis. These main market players are continuously engaged in various business development activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations to expand their business operations and widen their geographical reach.
Our Clients
Related Reports
Some other reports from this category!
